Skip to main content
SpringerLink
Log in

PGx testing reduces drug costs in psychiatric patients

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. central nervous system

Reference

  • Brown LC, et al. Economic Utility: Combinatorial Pharmacogenomics and Medication Cost Savings for Mental Health Care in a Primary Care Setting. Clinical Therapeutics : 18 Feb 2017. Available from: URL: http://doi.org/10.1016/j.clinthera.2017.01.022

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

PGx testing reduces drug costs in psychiatric patients. PharmacoEcon Outcomes News 773, 29 (2017). https://doi.org/10.1007/s40274-017-3814-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-3814-1

Search

Navigation